Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food effect study of JLP-2004 in healthy volunteers
NCT06431399Phase 1Recruiting
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Start
- Apr 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of JLP-2004 in pain (2 arms), sponsored by Jeil Pharmaceutical Co., Ltd. Primary endpoints: Area under the concentration-time curve from time zero to the last measurable concentration at 24 hours and Maximum observed plasma concentration at 24 hours. Started Apr 2024; status: recruiting.
02
Drugs
JLP-2004
03
Conditions
pain
Beyond the preview
Go deeper on NCT06431399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06431399.